BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,195.00
+10.00 (0.31%)
Last updated: Dec 5, 2025, 10:19 AM KST
8.49%
Market Cap25.97B
Revenue (ttm)18.65B
Net Income (ttm)-246.68M
Shares Out8.18M
EPS (ttm)-30.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,071
Average Volume13,303
Open3,185.00
Previous Close3,185.00
Day's Range3,185.00 - 3,215.00
52-Week Range2,750.00 - 4,390.00
Beta1.24
RSI34.70
Earnings DateNov 14, 2025

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.